Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer (Q36032993)

11 August 2017

Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer (English)

1 reference

11 August 2017

2

Dimitris Visvikis

1 reference

11 August 2017

Mathieu Hatt

1

1 reference

11 August 2017

Olivier Pradier

series ordinal

3

1 reference

11 August 2017

Catherine Cheze-le Rest

series ordinal

4

1 reference

11 August 2017

11 May 2011

1 reference

11 August 2017

12

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

11 August 2017

38

1 reference

11 August 2017

9

1 reference

11 August 2017

1595-1606

1 reference

Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Global cancer statistics, 2002

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Basic principles of ROC analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Restaging: should we percist without pattern recognition?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

11 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

PET functional volume delineation: a robustness and repeatability study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1834-9

Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3375481

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

23 September 2018

1 reference

12 December 2020

Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology

1 reference

12 December 2020

Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography

1 reference

12 December 2020

Evaluation of Response to Neoadjuvant Therapy by Quantitative 2-Deoxy-2-[F]Fluoro-D-Glucose with Positron Emission Tomography in Patients with Esophageal Cancer

1 reference

12 December 2020

Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer

1 reference

12 December 2020

Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation

1 reference

12 December 2020

Esophageal tumor length is independently associated with long-term survival

1 reference

12 December 2020

10.1007/S00259-011-1834-9

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

21559979

1 reference